Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: Can we rely on large randomized control trials in the era of personalized medicine?

S. Glück

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1937-1938
Number of pages2
JournalAnnals of Oncology
Issue number9
StatePublished - Sep 2011

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this